MOPONETUG
UNII H85U6L98FB

Substance Identification & Data

This profile provides standardized clinical and technical data for Moponetug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H85U6L98FB.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3031519-40-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

H85U6L98FB

CAS Registry Number

3031519-40-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MOPONETUG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C223293

National Cancer Institute reference terminology for clinical and research data.

INN ID

13775

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-236

Identifier assigned by the United States Adopted Names Council.

Substance Type

Moponetug

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Moponetug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Moponetug

Common Names & Synonyms

Immunoglobulin G1, anti-(human/Macaca fascicularis/Rattus norvegicus tau protein) (human-Mus musculus monoclonal BMS-986446 γ1-chain), disulfide with human-Mus musculus monoclonal BMS-986446 κ-chain, dimer

Immunoglobulin G1-kappa, anti-[Homo sapiens microtubule-associated protein tau (MAPT), Neurofibrillary tangle protein, paired helical filament-tau (PHF-tau)], humanized monoclonal antibody; H-gamma1 heavy chain humanized (1-452) [VH (Homo sapiens IGHV1-69-2*01 (74.5%) -(IGHD) - IGHJ1*01 (100%), CDR-IMGT [8.8.5] (26-33.51-58.97-101)) (1-112) -Homo sapiens IGHG1*15, (CH1 (113-210), hinge 1-15 (211- 225), CH2 (226-235), CH3 D12>E (351), L14>M (353) (336-440), CHS (441-442)) (113-442)], (215-219')-disulfide with L-kappa light chain humanized (1'-219') [V- KAPPA (Homo sapiens IGKV2-30*02 (90.0%) - IGKJ2*01 (91.7%) Q120>G (105'), CDR-IMGT [11.3.9] (27'-37'.55'-57'.94'-102')) (1'-112') -Homo sapiens IGKC*01 (100%), Km3 A45.1 (158'), V101 (196') (113'-219')]; dimer (221-221'':224-224'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, glycoform alfa

MOPONETUG [USAN]

moponetug [INN]